Search

Search Constraints

You searched for: Author/Creator Nikolousis, Emmanouil

Search Results

1. Autoimmune Cytopenias Developing Late Post Alemtuzumab-Based Allogeneic Stem Cell Transplantation: Presentation of Short Case Series from a Transplant Center. (14th August 2020)

2. COVID‐19 in bone marrow transplant recipients: reflecting on a single centre experience. (23rd June 2020)

3. First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation. (2020)

5. Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations. (22nd January 2021)

6. Management of older patients with frailty and acute myeloid leukaemia: A British Society for Haematology good practice paper. (24th August 2022)

7. Mixed T-cell chimerism at 3 months followed by donor lymphocyte infusion is independently associated with favorable outcomes in alemtuzumab-based reduced-intensity allogeneic hematopoietic stem cell transplantation. Issue 1 (2nd January 2020)

8. Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma: reflections on a single center experience. Issue 12 (15th October 2019)

9. Reduced‐intensity conditioning allogeneic transplantation after salvage treatment with DT‐PACE in myeloma patients relapsing early after autologous transplant. (20th July 2017)

10. Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease. (August 2019)